The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Large Animals Drugs-Global Market Insights and Sales Trends 2025
Synopsis
The global Large Animals Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Large Animals Drugs in various end use industries. The expanding demands from the Veterinary Hospitals, Veterinary Clinics and Others,, are propelling Large Animals Drugs market. Molecular Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunodiagnostics segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Large Animals Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Large Animals Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Large Animals Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Large Animals Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Large Animals Drugs covered in this report include Boehringer Ingelheim, Zoetis, IDEXX Laboratories, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Dechra Veterinary Products, Parnell and Abaxis, etc.
The global Large Animals Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories
Global Large Animals Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Large Animals Drugs market, Segment by Type:
Molecular Diagnostics
Immunodiagnostics
Global Large Animals Drugs market, by Application
Veterinary Hospitals
Veterinary Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Large Animals Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Large Animals Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Large Animals Drugs in various end use industries. The expanding demands from the Veterinary Hospitals, Veterinary Clinics and Others,, are propelling Large Animals Drugs market. Molecular Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunodiagnostics segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Large Animals Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Large Animals Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Large Animals Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Large Animals Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Large Animals Drugs covered in this report include Boehringer Ingelheim, Zoetis, IDEXX Laboratories, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Dechra Veterinary Products, Parnell and Abaxis, etc.
The global Large Animals Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories
Global Large Animals Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Large Animals Drugs market, Segment by Type:
Molecular Diagnostics
Immunodiagnostics
Global Large Animals Drugs market, by Application
Veterinary Hospitals
Veterinary Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Large Animals Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Large Animals Drugs
1.1 Large Animals Drugs Market Overview
1.1.1 Large Animals Drugs Product Scope
1.1.2 Large Animals Drugs Market Status and Outlook
1.2 Global Large Animals Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Large Animals Drugs Market Size by Region (2018-2029)
1.4 Global Large Animals Drugs Historic Market Size by Region (2018-2023)
1.5 Global Large Animals Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Large Animals Drugs Market Size (2018-2029)
1.6.1 North America Large Animals Drugs Market Size (2018-2029)
1.6.2 Europe Large Animals Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Large Animals Drugs Market Size (2018-2029)
1.6.4 Latin America Large Animals Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Large Animals Drugs Market Size (2018-2029)
2 Large Animals Drugs Market by Type
2.1 Introduction
2.1.1 Molecular Diagnostics
2.1.2 Immunodiagnostics
2.2 Global Large Animals Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Large Animals Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Large Animals Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Large Animals Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Large Animals Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Large Animals Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Large Animals Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Large Animals Drugs Revenue Breakdown by Type (2018-2029)
3 Large Animals Drugs Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Hospitals
3.1.2 Veterinary Clinics
3.1.3 Others
3.2 Global Large Animals Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Large Animals Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Large Animals Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Large Animals Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Large Animals Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Large Animals Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Large Animals Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Large Animals Drugs Revenue Breakdown by Application (2018-2029)
4 Large Animals Drugs Competition Analysis by Players
4.1 Global Large Animals Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Large Animals Drugs as of 2022)
4.3 Date of Key Players Enter into Large Animals Drugs Market
4.4 Global Top Players Large Animals Drugs Headquarters and Area Served
4.5 Key Players Large Animals Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Large Animals Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Profile
5.1.2 Boehringer Ingelheim Main Business
5.1.3 Boehringer Ingelheim Large Animals Drugs Products, Services and Solutions
5.1.4 Boehringer Ingelheim Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Boehringer Ingelheim Recent Developments
5.2 Zoetis
5.2.1 Zoetis Profile
5.2.2 Zoetis Main Business
5.2.3 Zoetis Large Animals Drugs Products, Services and Solutions
5.2.4 Zoetis Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Zoetis Recent Developments
5.3 IDEXX Laboratories
5.3.1 IDEXX Laboratories Profile
5.3.2 IDEXX Laboratories Main Business
5.3.3 IDEXX Laboratories Large Animals Drugs Products, Services and Solutions
5.3.4 IDEXX Laboratories Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Elanco Animal Health Recent Developments
5.4 Elanco Animal Health
5.4.1 Elanco Animal Health Profile
5.4.2 Elanco Animal Health Main Business
5.4.3 Elanco Animal Health Large Animals Drugs Products, Services and Solutions
5.4.4 Elanco Animal Health Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Elanco Animal Health Recent Developments
5.5 Bayer Animal Health
5.5.1 Bayer Animal Health Profile
5.5.2 Bayer Animal Health Main Business
5.5.3 Bayer Animal Health Large Animals Drugs Products, Services and Solutions
5.5.4 Bayer Animal Health Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Animal Health Recent Developments
5.6 Merck Animal Health
5.6.1 Merck Animal Health Profile
5.6.2 Merck Animal Health Main Business
5.6.3 Merck Animal Health Large Animals Drugs Products, Services and Solutions
5.6.4 Merck Animal Health Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Animal Health Recent Developments
5.7 Dechra Veterinary Products
5.7.1 Dechra Veterinary Products Profile
5.7.2 Dechra Veterinary Products Main Business
5.7.3 Dechra Veterinary Products Large Animals Drugs Products, Services and Solutions
5.7.4 Dechra Veterinary Products Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Dechra Veterinary Products Recent Developments
5.8 Parnell
5.8.1 Parnell Profile
5.8.2 Parnell Main Business
5.8.3 Parnell Large Animals Drugs Products, Services and Solutions
5.8.4 Parnell Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Parnell Recent Developments
5.9 Abaxis
5.9.1 Abaxis Profile
5.9.2 Abaxis Main Business
5.9.3 Abaxis Large Animals Drugs Products, Services and Solutions
5.9.4 Abaxis Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Abaxis Recent Developments
5.10 Virbac
5.10.1 Virbac Profile
5.10.2 Virbac Main Business
5.10.3 Virbac Large Animals Drugs Products, Services and Solutions
5.10.4 Virbac Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Virbac Recent Developments
5.11 Ceva
5.11.1 Ceva Profile
5.11.2 Ceva Main Business
5.11.3 Ceva Large Animals Drugs Products, Services and Solutions
5.11.4 Ceva Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Ceva Recent Developments
5.12 Meiji
5.12.1 Meiji Profile
5.12.2 Meiji Main Business
5.12.3 Meiji Large Animals Drugs Products, Services and Solutions
5.12.4 Meiji Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 Meiji Recent Developments
5.13 Vetoquinol
5.13.1 Vetoquinol Profile
5.13.2 Vetoquinol Main Business
5.13.3 Vetoquinol Large Animals Drugs Products, Services and Solutions
5.13.4 Vetoquinol Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.13.5 Vetoquinol Recent Developments
5.14 Ouro Fino Saude
5.14.1 Ouro Fino Saude Profile
5.14.2 Ouro Fino Saude Main Business
5.14.3 Ouro Fino Saude Large Animals Drugs Products, Services and Solutions
5.14.4 Ouro Fino Saude Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.14.5 Ouro Fino Saude Recent Developments
5.15 Animalcare Group
5.15.1 Animalcare Group Profile
5.15.2 Animalcare Group Main Business
5.15.3 Animalcare Group Large Animals Drugs Products, Services and Solutions
5.15.4 Animalcare Group Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.15.5 Animalcare Group Recent Developments
5.16 IDvet
5.16.1 IDvet Profile
5.16.2 IDvet Main Business
5.16.3 IDvet Large Animals Drugs Products, Services and Solutions
5.16.4 IDvet Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.16.5 IDvet Recent Developments
5.17 Shenzhen Mindray Bio-Medical
5.17.1 Shenzhen Mindray Bio-Medical Profile
5.17.2 Shenzhen Mindray Bio-Medical Main Business
5.17.3 Shenzhen Mindray Bio-Medical Large Animals Drugs Products, Services and Solutions
5.17.4 Shenzhen Mindray Bio-Medical Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.17.5 Shenzhen Mindray Bio-Medical Recent Developments
5.18 Bio-Rad Laboratories
5.18.1 Bio-Rad Laboratories Profile
5.18.2 Bio-Rad Laboratories Main Business
5.18.3 Bio-Rad Laboratories Large Animals Drugs Products, Services and Solutions
5.18.4 Bio-Rad Laboratories Large Animals Drugs Revenue (US$ Million) & (2018-2023)
5.18.5 Bio-Rad Laboratories Recent Developments
6 North America
6.1 North America Large Animals Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Large Animals Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Large Animals Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Large Animals Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Large Animals Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Large Animals Drugs Market Dynamics
11.1 Large Animals Drugs Industry Trends
11.2 Large Animals Drugs Market Drivers
11.3 Large Animals Drugs Market Challenges
11.4 Large Animals Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
